hotspot -WSS

hotspot

author：hotspot 2025-10-01 04:13:37 - browse：54897

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Bird flu outbreak in cows is latest avian flu curveball

explore

leisure time

WSS

Getting Alzheimer's drug Leqembi to patients can be a challenge

UnitedHealth financials solid despite Change Healthcare cyberattack

Prime Medicine, Myeloid Therapeutics clash over genome

David Ricks of Eli Lilly: best biopharma CEO of 2023

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Readout Newsletter: The latest on Moderna, Apellis, and Merck

knowledge

hotspot

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

Three trends to watch in biotech in 2024

Activists slam private health insurers over coverage restrictions

FTC falls short on scrutinizing hospital mergers, study says

In Memoriam: Notable people who died in 2023

Can sheer will power keep patients alive in their dying hours?

Supreme Court strikes down use of affirmative action

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Hollywood unions extend contract negotiations for actors

Editas, Vertex strike deal on CRISPR

Wikipedia

UnitedHealth financials solid despite Change Healthcare cyberattack

Grail spinoff by Illumina should end disastrous merger attempt

Why rehabilitation engineers need to center patients in their research

Cell therapy fails to slow type 1 diabetes, but safety is established

How to keep neuroscience’s past racism from being its future

Dogs on Prozac: What pet anti

explore

explore

leisure time

hotspot